Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 21   

Articles published

ANTH 1.64 +0.03 (1.99%)
price chart
The 52-Week Low Club for Friday
Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) dropped about 2.3% on Friday to a new 52-week low of $2.33. Share volume is about equal to the daily average of around 127,000.
Anthera Pharmaceuticals Sets New 12-Month Low at $2.38 (ANTH)  WKRB News
Related articles »  
Stocks Watch List � Anthera Pharmaceuticals Inc (NASDAQ:ANTH), Guess?, Inc ...
Las Vegas, NV - September 18, 2014 - (Techsonian) - ValuePennyStocks.com provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.
Related articles »  
News Buzz- Anthera Pharmaceuticals Inc (NASDAQ:ANTH), HealthequityInc ...
Birmingham, West Midlands - (TechSonian) - 12th September 2014 - Anthera Pharmaceuticals Inc (NASDAQ:ANTH) declared financial results and operational update for the second quarter ended June 30, 2014.
Anthera Pharmaceuticals Sets New 52-Week Low at $2.16 (ANTH)
Anthera Pharmaceuticals (NASDAQ:ANTH) last posted its quarterly earnings results on Monday, July 28th. The company reported ($0.34) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.49) by $0.15.
Hot News : Anthera Pharmaceuticals (NASDAQ:ANTH), Exxon Mobil (NYSE ...
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Anthera Pharmaceuticals Hits New 12-Month Low at $2.39 (ANTH)
Anthera Pharmaceuticals logo Anthera Pharmaceuticals (NASDAQ:ANTH) reached a new 52-week low on Thursday , American Banking News reports.
Stocks Buzz- Lattice Semiconductor (NASDAQ:LSCC), Oxygen ...
Oxygen BiotherapeuticsInc (NASDAQ:OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, declared that the Company received shareholder approval to change the ...
Related articles »  
Active Stocks : AOL Inc. (NYSE:AOL), Tyson Foods (NYSE:TSN), eLong Inc ...
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) studied sPLA2 inhibition for acute coronary syndrome also using LY315920NA/S-5920, but the trial failed in Phase III.
Stocks Hitting 52-Week Lows
Oncolytics Biotech (NASDAQ: ONCY) shares fell 42.52% to touch a new 52-week low of $0.73 after the company reported overall and KRAS-mutated patient data from U.S.
Related articles »  
Investment Options: Oncolytics Biotech, Inc. (USA)(NASDAQ:ONCY), The Procter ...
New York, NY - (NISMAGAZINE) - 09/18/2014 - UltimateStockAlerts provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.
Related articles »